Additionally, our analysis of public single-cell sequencing data revealed that C1qbp-positive TAMs exhibit more immunosuppressive interactions with tumor cells compared to C1qbp-negative TAMs in TNBC patients, including CD47-SIRPα (Figure S9A-C). Here, C1QBP is linked to neoplasm.